Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece.

Saved in:
Bibliographic Details
Title: Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece.
Authors: Dardiotis, Efthymios1 (AUTHOR), Perpati, Georgia2 (AUTHOR), Borsos, Mariann3 (AUTHOR), Nikolaidis, Ioannis4 (AUTHOR), Tzanetakos, Dimitrios5 (AUTHOR), Deretzi, Georgia6 (AUTHOR), Koutlas, Evangelos6 (AUTHOR), Kilidireas, Constantinos5 (AUTHOR), Mitsikostas, Dimos Dimitrios5 (AUTHOR), Hadjigeorgiou, Georgios1 (AUTHOR), Grigoriadis, Nikolaos4 (AUTHOR) ngrigoriadis@auth.gr, The AURELIO investigators (AUTHOR), Papagiannopoulos, Sotirios (AUTHOR), Orologas, Anastasios (AUTHOR), Aggelidakis, Panagiotis (AUTHOR), Antonios, Antonios (AUTHOR), Fakas, Nicolaos (AUTHOR), Papadimitriou, Alexandros (AUTHOR), Iliopoulos, Ioannis (AUTHOR), Kostadima, Vasiliki (AUTHOR)
Source: Neurology & Therapy. Sep2022, Vol. 11 Issue 3, p1375-1390. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-022-00384-2